摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-(3-chlorophenyl)-2H-pyrazol-3-yl]-1-(2-chloropyridin-4-yl)-1H-pyridazin-4-one | 1240648-50-3

中文名称
——
中文别名
——
英文名称
3-[2-(3-chlorophenyl)-2H-pyrazol-3-yl]-1-(2-chloropyridin-4-yl)-1H-pyridazin-4-one
英文别名
3-[2-(3-Chlorophenyl)pyrazol-3-yl]-1-(2-chloropyridin-4-yl)pyridazin-4-one
3-[2-(3-chlorophenyl)-2H-pyrazol-3-yl]-1-(2-chloropyridin-4-yl)-1H-pyridazin-4-one化学式
CAS
1240648-50-3
化学式
C18H11Cl2N5O
mdl
——
分子量
384.224
InChiKey
LTXXUFVDFJKUSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.4
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES
    申请人:Alberati Daniela
    公开号:US20100216793A1
    公开(公告)日:2010-08-26
    The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R 1 , R 2 , R 3 and R 4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
    本发明涉及具有如下式(I)的新型吡啶并嗪酮衍生物,其中R1、R2、R3和R4如描述和索赔中所定义,并且其生理上可接受的盐和酯。这些化合物抑制PDE10A并可用作药物。
  • Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
    申请人:McDaniel C. Steven
    公开号:US20100210745A1
    公开(公告)日:2010-08-19
    Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.
    本文公开了一些聚合材料,如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂;一种表面处理,如纺织品涂层或蜡;一种填料,用于这样的聚合材料或表面处理,其中包括一种酶,如酯酶(例如,脂肪解酶,硫酸酯解酶,有机化合物降解酶),降解细胞壁和/或细胞膜成分的酶(例如,溶菌酶,裂解转糖基酶),生物杀菌或生物静态肽,以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪解酶、解酶和/或酶的活性交联材料中来改变材料性能,如使用寿命、柔韧性或刚度的方法。
  • Anti-fouling Paints and Coatings
    申请人:Reactive Surfaces LTD
    公开号:US20150191607A1
    公开(公告)日:2015-07-09
    Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peptide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.
    本文披露了聚合材料,例如涂层、塑料、层压材料、复合材料、弹性体、粘合剂或密封剂;表面处理,例如纺织品整理或蜡;填充剂,用于这种聚合材料或表面处理,包括酯酶(例如脂肪解酶、硫酸酯解酶、有机化合物降解酶)的酶,降解细胞壁和/或细胞膜成分的酶(例如溶菌酶、裂解转葡糖苷酶),生物杀菌或生物稳定肽,和/或肽酶。本文还披露了通过将酶并入能够通过脂肪解酶、解酶和/或酶的活性进行化学交联的材料中,改变材料性能(例如使用寿命、柔韧性或刚度)的方法。
  • US9187455B2
    申请人:——
    公开号:US9187455B2
    公开(公告)日:2015-11-17
  • [EN] HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDAZONE À SUBSTITUTION HÉTÉROARYLE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2010094762A1
    公开(公告)日:2010-08-26
    The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.
查看更多